October 1, 2015

Kevin Hammond, Managing Director of JLL Partners said, "Under the leadership of ATS's CEO, Matt Yerbic, the Company has built an outstanding team of industry veterans and grown significantly by expanding its relationships with key customers and partners. JLL's investment will provide ATS with ample resources to evolve its offerings within engineering and...

September 21, 2015

NEWTOWN, Pa. - September 21, 2015 – BioClinica®, Inc., a specialty clinical trials services and technology provider, today announced that it has acquired Synowledge to expand its offering into the growing drug safety and regulatory business process outsourcing market. Headquartered in Miami, Synowledge specializes in pharmacovigilance, regulatory affairs...

June 15, 2015

New York, NY (June 1, 2015) – JLL Partners, a middle market private equity firm based in New York, announced today that it has acquired Point Blank Enterprises ("Point Blank" or the "Company") from an affiliate of Sun Capital Partners, Inc. The terms of the transaction were not disclosed.

Headquartered in Pompano Beach, Florida, Point Blank is the largest...

March 12, 2014

JLL Partners (JLL), the middle-market private equity firm, and Royal DSM (Euronext: DSM KON), the global Life Sciences and Materials Sciences company, today announced the successful closing of the transaction announced in November 2013 combining DSM Pharmaceutical Products (DPP) and Patheon Inc. into a new privately held company, named DPx Holdings B.V. (...

March 12, 2014

This article is written by David Carey, and was originally published at http://www.bloomberg.com/news/2014-03-11/jll-s-two-deals-cap-1-7-billion-payback-over-15-months.html.

JLL Partners Inc., a 26-year-old private-equity firm based in New York, boosted the cash it has returned to fund investors since the start of last year to $1.7 billion by wrapping up t...

March 12, 2014

Durham, N.C. — (March 11, 2014)—DPx Holdings B.V. (DPx), privately owned by JLL Partners and Royal DSM, today launched as a leading global contract development and manufacturing organization (CDMO) for the pharmaceutical and related industries. DPx is the result of a USD $2.65 billion transaction between JLL Partners, a leading middle-market private equit...

March 11, 2014

CHICAGO and NEW YORK – March 12, 2014 – Water Street Healthcare Partners, a strategic investor focused exclusively on the health care industry, and JLL Partners, a leading middle-market private equity firm, announced today that they have merged their companies CCBR-SYNARC and BioClinica, Inc. The combination creates a leading global provider of specialty...

November 19, 2013

JLL Partners (“JLL”), a leading middle-market private equity firm, and Royal DSM, the global Life Sciences and Materials Sciences company, today announced the creation of a new company, which will be a leading global contract development and manufacturing organization (CDMO) for the pharmaceutical industry with anticipated sales of around USD 2 billion. I...

November 13, 2013

JLL Partners Inc., a New York-based private-equity firm, agreed to buy a majority stake in vitamin-maker Royal DSM NV (DSM)’s pharmaceuticals business to create a new company in a deal valued at $2.6 billion.

The unit will be rolled into Patheon Inc. (PTI), a Canada-based specialty-pharmaceuticals manufacturer controlled by JLL, the companies said in a joi...

October 2, 2013

Dominant player positioned to capture secular growth in impact products market.  PGT, Inc. (PGTI) is uniquely positioned to benefit from the strong rebound in the Florida housing market and rapidly grow sales of its impact-resistant windows and doors products. 

Download the report here.

Please reload